Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-022218

VP Finance & Operations sold 455 shares at an average $0.68 ($310)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mitrano Richard J. · VP Finance & Operations

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-04 Sale : show line 1 in the form 10b5-1 −220 $0.67 $147 51,052 D
2023-08-07 Sale : show line 2 in the form 10b5-1 −235 $0.69 $162 50,817 D
Open-market sales · 455 sh · avg $0.68 · $310
Loading xslF345X05/form4.xml…